Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Old National Bancorp
ONB
$10.4B
| $48.5M | 0.01% |
3,280,509
+2,735,921
| +502% | +$42.1M |
|
1002
Lear
LEA
$8.16B
| $48.4M | 0.01% |
384,628
+357,101
| +1,297% | +$47.1M |
|
|
K
1003
CALL
DELISTED
Kellanova
K
| $48.4M | 0.01% |
722,070
+110,973
| +18% | +$7.21M |
|
1004
First Interstate BancSystem
FIBK
$3.7B
| $48.3M | 0.01% |
1,266,613
-543,510
| -30% | -$19.4M |
|
1005
CALL
CarMax
KMX
$8.33B
| $48.1M | 0.01% |
531,500
+28,600
| +6% | +$2.69M |
|
|
SGFY
1006
DELISTED
Signify Health, Inc.
SGFY
| $48.1M | 0.01% |
3,483,124
+352,626
| +11% | +$4.96M |
|
1007
CALL
iShares Semiconductor ETF
SOXX
$46.6B
| $47.9M | 0.01% |
411,000
+64,800
| +19% | +$8.74M |
|
|
AYX
1008
DELISTED
Alteryx Inc
AYX
| $47.8M | 0.01% |
987,920
+228,915
| +30% | +$13.7M |
|
1009
Ares Management
ARES
$32.1B
| $47.8M | 0.01% |
841,250
-151,150
| -15% | -$10.5M |
|
|
SIVB
1010
CALL
DELISTED
SVB Financial Group
SIVB
| $47.8M | 0.01% |
121,000
+38,700
| +47% | +$18.2M |
|
1011
PUT
GSK
GSK
$101B
| $47.8M | 0.01% |
878,240
+194,320
| +28% | +$10.7M |
|
1012
Synchrony
SYF
$25.8B
| $47.7M | 0.01% |
1,727,825
-1,727,830
| -50% | -$60M |
|
1013
SLB Ltd
SLB
$78.1B
| $47.7M | 0.01% |
1,332,587
+612,307
| +85% | +$25.5M |
|
|
VTYX
1014
DELISTED
Ventyx Biosciences
VTYX
| $47.6M | 0.01% |
3,891,328
-20,582
| -0.5% | -$308K |
|
1015
PUT
HSBC
HSBC
$358B
| $47.6M | 0.01% |
1,455,800
-530,000
| -27% | -$17.2M |
|
1016
CALL
Fair Isaac
FICO
$24B
| $47.5M | 0.01% |
118,600
+70,900
| +149% | +$28M |
|
1017
Delek US
DK
$4.12B
| $47.5M | 0.01% |
1,839,724
+390,447
| +27% | +$10.5M |
|
1018
CALL
Cameco
CCJ
$43.1B
| $47.4M | 0.01% |
2,257,000
+1,067,900
| +90% | +$26.9M |
|
1019
PUT
Equinix
EQIX
$105B
| $47.4M | 0.01% |
72,200
+1,900
| +3% | +$1.32M |
|
1020
CALL
HCA Healthcare
HCA
$89.8B
| $47.4M | 0.01% |
282,200
+59,300
| +27% | +$12.7M |
|
1021
CALL
Paycom
PAYC
$9.52B
| $47.3M | 0.01% |
168,900
+54,100
| +47% | +$16M |
|
1022
PUT
Suncor Energy
SU
$76.5B
| $47.3M | 0.01% |
1,347,500
+182,200
| +16% | +$6.63M |
|
1023
PagerDuty
PD
$876M
| $47.1M | 0.01% |
1,900,788
+964,916
| +103% | +$26.5M |
|
1024
CALL
HubSpot
HUBS
$12B
| $47.1M | 0.01% |
156,500
+26,500
| +20% | +$9.68M |
|
1025
CALL
Danaos Corp
DAC
$2.55B
| $47M | 0.01% |
745,400
+391,500
| +111% | +$31.4M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.